Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

22.24
Delayed Data
As of Jul 21
 +0.07 / +0.32%
Today’s Change
11.41
Today|||52-Week Range
24.88
+81.26%
Year-to-Date

Today’s Trading

Previous close22.17
Today’s open22.19
Day’s range21.98 - 22.82
Volume1,871,801
Average volume (3 months)1,792,369
Market cap$3.5B
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-13.51%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book38.67

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+0.65+2.24%
XONIntrexon Corp-0.04-0.17%
NBIXNeurocrine Bioscienc...-0.72-1.51%
AVXSAveXis Inc+0.56+0.67%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts